3D range-modulator for scanned particle therapy: development, Monte Carlo simulations and experimental evaluation
Yuri Simeonov1, Uli Weber2, Petar Penchev1
1Institute of Medical Physics and Radiation Protection (IMPS), University of Applied Sciences, Giessen, Germany.
Physics in Medicine and Biology
|July 26, 2017
Summary
A novel 3D range-modulator significantly reduces particle therapy treatment time by using a single energy beam. This technology minimizes interplay effects, offering a faster, more reliable approach for treating moving tumors like lung cancer.
Area of Science:
- Medical Physics
- Radiation Oncology
- Biomedical Engineering
Background:
- Particle therapy offers precise radiation delivery but can involve lengthy treatment times.
- Modulating beam energy is crucial for conformal dose distribution, but multi-energy plans are time-consuming.
- Interplay effects in scanned particle beams can compromise dose homogeneity, especially for moving targets.
Purpose of the Study:
- To design and manufacture a 3D range-modulator for scanned particle therapy.
- To achieve highly conformal dose distributions using a single fixed beam energy.
- To substantially reduce overall treatment time and mitigate interplay effects.
Main Methods:
- A 3D range-modulator was designed using thin pins of varying lengths to modulate the Bragg peak.
- Rapid prototyping was employed for modulator fabrication.
- FLUKA Monte Carlo simulations, including a custom user routine and intensity-modulated scanning, were used to model dose distribution.
- Experimental validation was performed using 400.41 MeV/u 12C beam at Heidelberg Ion Beam Therapy Center.
Main Results:
- Simulated and measured dose distributions showed good agreement.
- A monoenergetic raster plan with the 3D range-modulator took only 3 seconds, a 20-fold reduction compared to a 16-energy plan.
- The modulator effectively modulated the Bragg peak for a spherical target at 25 cm depth in a water phantom.
Conclusions:
- The 3D range-modulator enables highly conformal dose distributions with a single energy, drastically reducing treatment time.
- This approach significantly reduces or eliminates interplay effects, enhancing dose homogeneity for moving targets.
- The technology shows promise for rapid and reliable clinical application, particularly for lung tumors.


